Belluscura (LSE:BELL) Interest Expense: £-0.85 Mil (TTM As of Jun. 2024)


What is Belluscura Interest Expense?

Belluscura LSE:BELL Interest Expense is £-0.85 Mil as of Jun. 2024.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Belluscura's interest expense for the six months ended in Jun. 2024 was £ -0.38 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.85 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Belluscura's Operating Income for the six months ended in Jun. 2024 was £ -3.85 Mil. Belluscura's Interest Expense for the six months ended in Jun. 2024 was £ -0.38 Mil. Belluscura did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Belluscura  (LSE:BELL) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Belluscura's Interest Expense for the six months ended in Jun. 2024 was £-0.38 Mil. Its Operating Income for the six months ended in Jun. 2024 was £-3.85 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2024 was £0.00 Mil.

Belluscura's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Belluscura did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Belluscura Interest Expense Historical Data

* Premium members only.

The historical data trend for Belluscura's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Belluscura Interest Expense Chart

Belluscura Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial -0.03 -0.03 -0.02 -0.02 -0.65

Belluscura Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.18 -0.48 -0.38

Belluscura Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of £-0.85 Mil mean?
Belluscura (LSE:BELL) has a Interest Expense of £-0.85 Mil as of Jun. 2024. Interest Expense is the amount a company pays on its long-term debt. View historical data on Belluscura and its competitors.
Is Belluscura's Interest Expense too high?
Belluscura's current Interest Expense is £-0.85 Mil.
How does Belluscura's Interest Expense compare to ABT and BSX?
Belluscura's Interest Expense of £-0.85 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Belluscura and its competitors. Belluscura's current Interest Expense is £-0.85 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Belluscura stock overvalued right now?
Belluscura (LSE:BELL) has a current Interest Expense of £-0.85 Mil. The current Interest Expense is £-0.85 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Belluscura (LSE:BELL), the current Interest Expense is £-0.85 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Belluscura Business Description

Address 15 Fetter Lane, Holborn, London, GBR, EC4A 1BW
Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The company has only one operating segment being the sale of oxygen concentrators in the United States. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.